201 related articles for article (PubMed ID: 10799478)
1. Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.
English WR; Puente XS; Freije JM; Knauper V; Amour A; Merryweather A; Lopez-Otin C; Murphy G
J Biol Chem; 2000 May; 275(19):14046-55. PubMed ID: 10799478
[TBL] [Abstract][Full Text] [Related]
2. Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.
Wang Y; Johnson AR; Ye QZ; Dyer RD
J Biol Chem; 1999 Nov; 274(46):33043-9. PubMed ID: 10551873
[TBL] [Abstract][Full Text] [Related]
3. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
5. MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.
Atkinson SJ; Roghi C; Murphy G
Biochem J; 2006 Aug; 398(1):15-22. PubMed ID: 16686598
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.
Llano E; Pendás AM; Freije JP; Nakano A; Knäuper V; Murphy G; López-Otin C
Cancer Res; 1999 Jun; 59(11):2570-6. PubMed ID: 10363975
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.
Puente XS; Pendás AM; Llano E; Velasco G; López-Otín C
Cancer Res; 1996 Mar; 56(5):944-9. PubMed ID: 8640782
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
9. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.
Matsumoto S; Katoh M; Saito S; Watanabe T; Masuho Y
Biochim Biophys Acta; 1997 Nov; 1354(2):159-70. PubMed ID: 9396633
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP.
Pei D
J Biol Chem; 1999 Mar; 274(13):8925-32. PubMed ID: 10085137
[TBL] [Abstract][Full Text] [Related]
11. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
[TBL] [Abstract][Full Text] [Related]
12. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
14. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage.
Pei D
Cell Res; 1999 Dec; 9(4):291-303. PubMed ID: 10628838
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
Stracke JO; Hutton M; Stewart M; Pendás AM; Smith B; López-Otin C; Murphy G; Knäuper V
J Biol Chem; 2000 May; 275(20):14809-16. PubMed ID: 10809722
[TBL] [Abstract][Full Text] [Related]
16. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.
Lafleur MA; Hollenberg MD; Atkinson SJ; Knäuper V; Murphy G; Edwards DR
Biochem J; 2001 Jul; 357(Pt 1):107-15. PubMed ID: 11415441
[TBL] [Abstract][Full Text] [Related]
17. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
Fillmore HL; VanMeter TE; Broaddus WC
J Neurooncol; 2001 Jun; 53(2):187-202. PubMed ID: 11716070
[TBL] [Abstract][Full Text] [Related]
18. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
[TBL] [Abstract][Full Text] [Related]
19. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
Black RA; Durie FH; Otten-Evans C; Miller R; Slack JL; Lynch DH; Castner B; Mohler KM; Gerhart M; Johnson RS; Itoh Y; Okada Y; Nagase H
Biochem Biophys Res Commun; 1996 Aug; 225(2):400-5. PubMed ID: 8753775
[TBL] [Abstract][Full Text] [Related]
20. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]